Boehringer Supports Ecuador Rabies Elimination Program
LYON, France, April 09, 2026 Boehringer Ingelheim has announced its continued support for Ecuador’s national effort to eliminate dog-mediated...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
LYON, France, April 09, 2026 Boehringer Ingelheim has announced its continued support for Ecuador’s national effort to eliminate dog-mediated...
BOXMEER, The Netherlands — October 23, 2025 — MSD Animal Health, a global leader in veterinary biopharmaceutical innovation, announced...
NORTH CHICAGO, Ill., October 29, 2025 — AbbVie Inc. (NYSE: ABBV) announced positive topline results from two replicate Phase...
INDIANAPOLIS, Ind., October 24, 2025 — In a landmark decision for veterinary medicine and regulatory preparedness, Elanco Animal Health...
RAHWAY, N.J., September 26, 2025 – Merck Animal Health, known as MSD Animal Health outside the U.S. and Canada...
MANHATTAN, Kan., August 2025 — Kansas State University, Iowa State University, and University College Dublin have announced a landmark...
